Literature DB >> 7883981

180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.

M F Jonkman1, M C de Jong, K Heeres, H H Pas, J B van der Meer, K Owaribe, A M Martinez de Velasco, C M Niessen, A Sonnenberg.   

Abstract

Generalized atrophic benign epidermolysis bullosa (GABEB) is a form of nonlethal junctional epidermolysis bullosa characterized by universal alopecia and atrophy of the skin. We report a deficiency of the 180-kD bullous pemphigoid antigen in three patients with GABEB from unrelated families. We screened specimens of clinically normal skin from nine junctional epidermolysis bullosa patients (3 GABEB, 4 lethal, 1 cicatricial, 1 pretibial) by immunofluorescence using monoclonal antibodies to the 180-kD and 230-kD bullous pemphigoid antigens (BP180 and BP230). In the skin of the three GABEB patients there was no reactivity with antibodies to BP180, whereas staining for BP230 was normal. In the skin of the other six, non-GABEB patients, included in this study the expression of BP180 and BP230 was normal. Immunoblot analysis of cultured keratinocytes from one of the GABEB patients also failed to detect BP180 antigen, whereas BP230 was present in normal amounts. The deficient expression of BP180 is reflected in the RNA message, as in Northern blot analysis a reduced amount of BP180 transcripts, although of normal length, were detected. Interestingly, in another GABEB patient there were not-involved areas of skin, in which blistering could not be induced by rubbing. Biopsy material from these areas showed interrupted staining for BP180. There was no staining for BP180 in areas of clinically normal but involved skin of this patient. In conclusion, this study reveals that the BP180 antigen is deficient and the BP180 mRNA is reduced in generalized atrophic benign epidermolysis bullosa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883981      PMCID: PMC441474          DOI: 10.1172/JCI117785

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA.

Authors:  K Li; K Tamai; E M Tan; J Uitto
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

3.  Basement membrane diversity detected by monoclonal antibodies.

Authors:  H Hessle; L Y Sakai; D W Hollister; R E Burgeson; E Engvall
Journal:  Differentiation       Date:  1984       Impact factor: 3.880

4.  Generalized atrophic benign epidermolysis bullosa.

Authors:  H Hintner; K Wolff
Journal:  Arch Dermatol       Date:  1982-06

5.  Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.

Authors:  J D Fine
Journal:  J Invest Dermatol       Date:  1985-07       Impact factor: 8.551

6.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants.

Authors:  T Hashimoto; M Amagai; T Ebihara; S Gamou; N Shimizu; T Tsubata; A Hasegawa; K Miki; T Nishikawa
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States.

Authors:  A S Paller; J D Fine; S Kaplan; R W Pearson
Journal:  Arch Dermatol       Date:  1986-06

9.  Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis.

Authors:  M J Tidman; R A Eady
Journal:  J Invest Dermatol       Date:  1986-01       Impact factor: 8.551

10.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.

Authors:  R S Labib; G J Anhalt; H P Patel; D F Mutasim; L A Diaz
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

View more
  28 in total

1.  The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome.

Authors:  S B Hopkinson; J C Jones
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes.

Authors:  J Koster; S van Wilpe; I Kuikman; S H M Litjens; A Sonnenberg
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

3.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

4.  Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors:  L Pulkkinen; D U Kim; J Uitto
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 5.  Cultured epithelial autografts: diving from surgery into matrix biology.

Authors:  M Raghunath; M Meuli
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

6.  Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa.

Authors:  B Gatalica; L Pulkkinen; K Li; K Kuokkanen; M Ryynänen; J A McGrath; J Uitto
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

7.  Integrin alpha 6 beta 4 forms a complex with the cytoskeletal protein HD1 and induces its redistribution in transfected COS-7 cells.

Authors:  C M Niessen; E H Hulsman; E S Rots; P Sánchez-Aparicio; A Sonnenberg
Journal:  Mol Biol Cell       Date:  1997-04       Impact factor: 4.138

8.  Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells.

Authors:  Xiaoman Xu; Jaana Mannik; Elena Kudryavtseva; Kevin K Lin; Lisa A Flanagan; Joel Spencer; Amelia Soto; Ning Wang; Zhongxian Lu; Zhengquan Yu; Edwin S Monuki; Bogi Andersen
Journal:  Dev Biol       Date:  2007-10-05       Impact factor: 3.582

9.  Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.

Authors:  Anna M G Pasmooij; Hendri H Pas; Maria C Bolling; Marcel F Jonkman
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  The molecular basis for inherited bullous diseases.

Authors:  B P Korge; T Krieg
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.